Spreadsheet: 0a5fde29-61d1-4477-b9f3-c940d8008d2b
Sheet: Sheet1

File #4, si RNA treatment, downregulated genes | Unnamed: 1 | Unnamed: 2 | Unnamed: 3 | Unnamed: 4
Category | Function Annotation | P-value | Molecules | # Molecules
Cell-To-Cell Signaling and Interaction | phagocytosis of connective tissue cells | 7.18e-06 | ITGA5, ITGB3, TLR3 | 3
Cell-To-Cell Signaling and Interaction | phagocytosis of fibroblasts | 0.000127 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | phagocytosis of eukaryotic cells | 0.00547 | ITGA5, ITGB3, TLR3 | 3
Cell-To-Cell Signaling and Interaction | phagocytosis of eye cell lines | 0.0108 | ITGB3 | 1
Cell-To-Cell Signaling and Interaction | phagocytosis of cells | 0.012 | ITGA5, ITGB3, TLR3 | 3
Cell-To-Cell Signaling and Interaction | binding of osteoclasts | 3.84e-05 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | binding of melanoma cells | 0.000127 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | binding of osteocytes | 0.000454 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | binding of leukocyte cell lines | 0.00053 | ITGA5, ITGB3, TNC | 3
Cell-To-Cell Signaling and Interaction | binding of leukocytes | 0.00149 | FGF2, [NAME], ITGB3, TNC | 4
Cell-To-Cell Signaling and Interaction | binding of leukemia cell lines | 0.00159 | ITGA5, ITGB3, TNC | 3
Cell-To-Cell Signaling and Interaction | binding of cancer cells | 0.00189 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | binding of lymphatic system cells | 0.0025 | FGF2, [NAME], ITGB3, TNC | 4
Cell-To-Cell Signaling and Interaction | binding of tumor cells | 0.00283 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | binding of bone cell lines | 0.00309 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | binding of mononuclear leukocytes | 0.00502 | FGF2, [NAME], TNC | 3
Cell-To-Cell Signaling and Interaction | binding of lymphoma cell lines | 0.00558 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | binding of blood cells | 0.00644 | FGF2, [NAME], ITGB3, TNC | 4
Cell-To-Cell Signaling and Interaction | binding of connective tissue cells | 0.00668 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | binding of adipose cell lines | 0.0108 | ITGA5 | 1
Cell-To-Cell Signaling and Interaction | binding of astrocytes | 0.0108 | ITGB3 | 1
Cell-To-Cell Signaling and Interaction | binding of bone-marrow-derived monocyte/macrophage precursor cells | 0.0108 | ITGA5 | 1
Cell-To-Cell Signaling and Interaction | binding of blood-derived mast cells | 0.0144 | ITGB3 | 1
Cell-To-Cell Signaling and Interaction | adhesion of muscle cells | 5.64e-05 | [NAME] (includes EG:59), [NAME], ITGB3 | 3
Cell-To-Cell Signaling and Interaction | adhesion of hepatic stellate cells | 7.66e-05 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | adhesion of embryonic stem cells | 0.000127 | ITGA5, SRF | 2
Cell-To-Cell Signaling and Interaction | adhesion of liver cells | 0.000191 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | adhesion of stem cells | 0.000191 | ITGA5, SRF | 2
Cell-To-Cell Signaling and Interaction | adhesion of fibroblast cell lines | 0.000343 | FGF2, [NAME], ITGB3 | 3
Cell-To-Cell Signaling and Interaction | adhesion of skin cancer cell lines | 0.000354 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | adhesion of fibroblasts | 0.000371 | ITGA5, ITGB3, TNC | 3
Cell-To-Cell Signaling and Interaction | adhesion of vascular smooth muscle cells | 0.000454 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | adhesion of connective tissue cells | 0.000773 | ITGA5, ITGB3, TNC | 3
Cell-To-Cell Signaling and Interaction | adhesion of embryonic cells | 0.000827 | ITGA5, SRF | 2
Cell-To-Cell Signaling and Interaction | adhesion of eukaryotic cells | 0.000886 | [NAME] (includes EG:59), [NAME], FGF2, [NAME], ITGB3, MAP2K1, SRF, TNC | 8
Cell-To-Cell Signaling and Interaction | adhesion of endothelial cell lines | 0.00166 | FGF2, [NAME], ITGB3 | 3
Cell-To-Cell Signaling and Interaction | adhesion of smooth muscle cells | 0.00168 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | adhesion of cord blood cells | 0.00362 | ITGA5 | 1
Cell-To-Cell Signaling and Interaction | adhesion of gonadal cell lines | 0.00425 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | adhesion of cancer cells | 0.00523 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | adhesion of tumor cells | 0.00668 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | adhesion of myofibroblasts | 0.00723 | [NAME] (includes EG:59) | 1
Cell-To-Cell Signaling and Interaction | adhesion of bone marrow stromal cells | 0.0108 | ITGA5 | 1
Cell-To-Cell Signaling and Interaction | adhesion of cells | 0.012 | [NAME] (includes EG:59), [NAME], FGF2, [NAME], ITGB3, MAP2K1, SRF, TNC | 8
Cell-To-Cell Signaling and Interaction | adhesion of epithelial cells | 0.012 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | adhesion of breast cancer cell lines | 0.0141 | CDCP1, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | adhesion of squamous cell carcinoma cell lines | 0.0144 | ITGA5 | 1
Cell-To-Cell Signaling and Interaction | activation of tumor cells | 0.00234 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | activation of bone marrow-derived macrophages | 0.00723 | UBE2N | 1
Cell-To-Cell Signaling and Interaction | activation of eukaryotic cells | 0.0115 | [NAME] (includes EG:59), FGF2, [NAME], ITGB3, [NAME], TNC, UBE2N | 7
Cell-To-Cell Signaling and Interaction | activation of cells | 0.0134 | [NAME] (includes EG:59), FGF2, [NAME], ITGB3, [NAME], TNC, UBE2N | 7
Cell-To-Cell Signaling and Interaction | attachment of muscle cell lines | 0.00362 | ITGB3 | 1
Cell-To-Cell Signaling and Interaction | attachment of cell lines | 0.0115 | ITGA5, ITGB3 | 2
Cell-To-Cell Signaling and Interaction | cross-priming of cytotoxic T lymphocytes | 0.00362 | [NAME] | 1
Cell-To-Cell Signaling and Interaction | cross-priming of T lymphocytes | 0.0108 | [NAME] | 1
Cell-To-Cell Signaling and Interaction | maturation of synapse | 0.00362 | ITGB3 | 1
Cell-To-Cell Signaling and Interaction | recruitment of preosteoblastic cells | 0.00362 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | recruitment of osteoblasts | 0.0108 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | response of carcinoma cell lines | 0.00362 | [NAME] | 1
Cell-To-Cell Signaling and Interaction | response of lung cancer cell lines | 0.00362 | [NAME] | 1
Cell-To-Cell Signaling and Interaction | stimulation of bone marrow stromal cells | 0.00362 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | stimulation of chromaffin cells | 0.00362 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | stimulation of megakaryocyte/erythrocyte lineage-restricted progenitor cells | 0.00362 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | stimulation of myoblasts | 0.00362 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | stimulation of adrenal gland cells | 0.00723 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | stimulation of neuroendocrine cells | 0.00723 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | stimulation of endocrine cell lines | 0.0108 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | stimulation of endocrine cells | 0.0108 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | stimulation of stem cells | 0.0108 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | stimulation of stromal cells | 0.0108 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | formation of focal adhesions | 0.0061 | FGF2, [NAME], ITGB3 | 3
Cell-To-Cell Signaling and Interaction | induction of oligodendrocytes | 0.00723 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | sensitization of fibroblast cell lines | 0.00723 | FGF2 | 1
Cell-To-Cell Signaling and Interaction | dynamics of cell-matrix contacts | 0.0108 | ITGA5 | 1
Cellular Function and Maintenance | phagocytosis of connective tissue cells | 7.18e-06 | ITGA5, ITGB3, TLR3 | 3
Cellular Function and Maintenance | phagocytosis of fibroblasts | 0.000127 | ITGA5, ITGB3 | 2
Cellular Function and Maintenance | phagocytosis of eukaryotic cells | 0.00547 | ITGA5, ITGB3, TLR3 | 3
Cellular Function and Maintenance | phagocytosis of eye cell lines | 0.0108 | ITGB3 | 1
Cellular Function and Maintenance | phagocytosis of cells | 0.012 | ITGA5, ITGB3, TLR3 | 3
Cellular Function and Maintenance | assembly of actin stress fibers | 7.48e-05 | ITGA5, ITGB3, TNC | 3
Cellular Function and Maintenance | assembly of actin filaments | 7.67e-05 | FGF2, [NAME], ITGB3, TNC | 4
Cellular Function and Maintenance | repair of cells | 0.00456 | FGF2, UBE2N | 2
Cellular Function and Maintenance | engulfment of eukaryotic cells | 0.00643 | ITGA5, ITGB3, TLR3 | 3
Cellular Function and Maintenance | regulation of stromal cells | 0.00723 | FGF2 | 1
Cellular Function and Maintenance | function of osteoclasts | 0.0108 | ITGB3 | 1
Cellular Function and Maintenance | localization of axons | 0.0108 | FGF2 | 1
[NAME] | phagocytosis of connective tissue cells | 7.18e-06 | ITGA5, ITGB3, TLR3 | 3
[NAME] | phagocytosis of fibroblasts | 0.000127 | ITGA5, ITGB3 | 2
[NAME] | phagocytosis of eukaryotic cells | 0.00547 | ITGA5, ITGB3, TLR3 | 3
[NAME] | phagocytosis of eye cell lines | 0.0108 | ITGB3 | 1
[NAME] | phagocytosis of cells | 0.012 | ITGA5, ITGB3, TLR3 | 3
[NAME] | cross-priming of cytotoxic T lymphocytes | 0.00362 | [NAME] | 1
[NAME] | cross-priming of T lymphocytes | 0.0108 | [NAME] | 1
[NAME] | stimulation of bone marrow stromal cells | 0.00362 | FGF2 | 1
[NAME] | activation of bone marrow-derived macrophages | 0.00723 | UBE2N | 1
[NAME] | accumulation of lymphatic system cells | 0.0141 | FGF2, [NAME], TLR3 | 3
Cancer | binding of melanoma cells | 0.000127 | ITGA5, ITGB3 | 2
Cancer | binding of leukemia cell lines | 0.00159 | ITGA5, ITGB3, TNC | 3
Cancer | binding of cancer cells | 0.00189 | ITGA5, ITGB3 | 2
Cancer | binding of tumor cells | 0.00283 | ITGA5, ITGB3 | 2
Cancer | binding of lymphoma cell lines | 0.00558 | ITGA5, ITGB3 | 2
Cancer | movement of melanoma cell lines | 0.000137 | CNN1, [NAME], ITGB3 | 3
Cancer | movement of breast cancer cell lines | 0.00445 | FGF2, [NAME], ITGB3 | 3
Cancer | movement of cancer cells | 0.013 | ITGA5, ITGB3 | 2
Cancer | size of breast cancer cell lines | 0.000191 | ITGA5, ITGB3 | 2
Cancer | size of tumor cell lines | 0.00456 | ITGA5, ITGB3 | 2
Cancer | metastasis | 0.000206 | CNN1, [NAME], FGF2, ITGB3, TUBB3 | 5
Cancer | metastasis of tumor cell lines | 0.00558 | CNN1, FABP5 | 2
Cancer | metastasis of cell lines | 0.00747 | CNN1, FABP5 | 2
Cancer | metastasis of eukaryotic cells | 0.0135 | CNN1, FABP5 | 2
Cancer | adhesion of skin cancer cell lines | 0.000354 | ITGA5, ITGB3 | 2
Cancer | adhesion of cancer cells | 0.00523 | ITGA5, ITGB3 | 2
Cancer | adhesion of tumor cells | 0.00668 | ITGA5, ITGB3 | 2
Cancer | adhesion of breast cancer cell lines | 0.0141 | CDCP1, ITGB3 | 2
Cancer | adhesion of squamous cell carcinoma cell lines | 0.0144 | ITGA5 | 1
Cancer | double-stranded DNA break repair of tumor cell lines | 0.000454 | FGF2, UBE2N | 2
Cancer | double-stranded DNA break repair of cervical cancer cell lines | 0.00723 | FGF2 | 1
Cancer | carcinoma | 0.00142 | [NAME] (includes EG:59), CFI, [NAME], FGF2, HIST2H2AA3, [NAME], ITGB3, MAP2K1, [NAME], TNC, TUBB3, ZFYVE26 | 12
Cancer | repair of tumor cell lines | 0.00149 | FGF2, UBE2N | 2
Cancer | repair of colon cancer cell lines | 0.0108 | UBE2N | 1
Cancer | arrest in G1 phase of colorectal cancer cell lines | 0.00168 | FGF2, ITGA5 | 2
Cancer | G1 phase of colorectal cancer cell lines | 0.00211 | FGF2, ITGA5 | 2
Cancer | G1 phase of tumor cell lines | 0.00212 | FGF2, HOXA10, [NAME], NASP | 4
Cancer | arrest in G1 phase of tumor cell lines | 0.00678 | FGF2, HOXA10, [NAME] | 3
Cancer | modification of tumor cell lines | 0.00189 | FGF2, UBE2N | 2
Cancer | tumorigenesis of melanoma cell lines | 0.00211 | CNN1, FGF2 | 2
Cancer | tumorigenesis of tumor cell lines | 0.00562 | CNN1, [NAME], FGF2 | 3
Cancer | tumorigenesis of sarcoma cell lines | 0.00723 | CNN1 | 1
Cancer | tumorigenesis | 0.0119 | [NAME] (includes EG:59), CFI, CNN1, [NAME], [NAME], FABP5, FGF2, HIST2H2AA3, HOXA10, [NAME], ITGB3, LIPH, MAP2K1, [NAME], TNC, TUBB3, ZFYVE26 | 17
Cancer | tumorigenesis of cell lines | 0.0135 | CNN1, [NAME], FGF2 | 3
Cancer | activation of tumor cells | 0.00234 | ITGA5, ITGB3 | 2
Cancer | disease process of melanoma cell lines | 0.00234 | CNN1, FGF2 | 2
Cancer | disease process of tumor cell lines | 0.0123 | CNN1, [NAME], FGF2 | 3
Cancer | survival of lung cancer cell lines | 0.00258 | FGF2, TUBB3 | 2
Cancer | endometrial adenocarcinoma | 0.00309 | FGF2, TUBB3 | 2
Cancer | arrest in interphase of colorectal cancer cell lines | 0.00336 | FGF2, ITGA5 | 2
Cancer | interphase of colorectal cancer cell lines | 0.0101 | FGF2, ITGA5 | 2
Cancer | interphase of tumor cell lines | 0.0143 | FGF2, HOXA10, [NAME], NASP | 4
Cancer | melanoma | 0.00347 | FGF2, ITGB3, MAP2K1, TUBB3 | 4
Cancer | genital tumor | 0.00355 | CFI, [NAME], HIST2H2AA3, ITGB3, TUBB3, ZFYVE26 | 6
Cancer | delay in G1/S phase transition of cervical cancer cell lines | 0.00362 | NASP | 1
Cancer | G1/S phase transition of cervical cancer cell lines | 0.0144 | NASP | 1
Cancer | clustering of pancreatic cancer cell lines | 0.00362 | FGF2 | 1
Cancer | colony survival of carcinoma cell lines | 0.00362 | TUBB3 | 1
Cancer | colony survival of lung cancer cell lines | 0.00362 | TUBB3 | 1
Cancer | differentiation of cholangiocarcinoma cell lines | 0.00362 | FGF2 | 1
Cancer | dissemination of melanoma cell lines | 0.00362 | CNN1 | 1
Cancer | hyperplasia of endothelial cells | 0.00362 | FGF2 | 1
Cancer | hyperplasia of mice | 0.00723 | MAP2K1 | 1
Cancer | hyperplasia of rodents | 0.0108 | MAP2K1 | 1
Cancer | response of carcinoma cell lines | 0.00362 | [NAME] | 1
Cancer | response of lung cancer cell lines | 0.00362 | [NAME] | 1
Cancer | transformation of chromaffin cells | 0.00362 | FGF2 | 1
Cancer | transformation of nerves | 0.00362 | HOXA10 | 1
Cancer | transformation of apud cells | 0.0108 | FGF2 | 1
Cancer | migration of melanoma cell lines | 0.00425 | ITGA5, ITGB3 | 2
Cancer | migration of breast cancer cell lines | 0.00432 | FGF2, [NAME], ITGB3 | 3
Cancer | migration of cancer cells | 0.0125 | ITGA5, ITGB3 | 2
Cancer | head and neck tumor | 0.00454 | FGF2, [NAME], ITGB3, TNC, TUBB3 | 5
Cancer | arrest in cell stage of colorectal cancer cell lines | 0.00456 | FGF2, ITGA5 | 2
Cancer | cell stage of tumor cell lines | 0.00674 | FGF2, HOXA10, [NAME], MAP2K1, NASP | 5
Cancer | proliferation of prostate cancer cell lines | 0.00473 | FABP5, FGF2, SRF | 3
Cancer | proliferation of medulloblastoma cells | 0.0108 | FGF2 | 1
Cancer | proliferation of tumor cell lines | 0.0121 | CNN1, [NAME], FGF2, [NAME], ITGB3, MAP2K1, SRF | 7
Cancer | neoplasia | 0.00513 | [NAME] (includes EG:59), CFI, CNN1, [NAME], [NAME], FABP5, FGF2, HIST2H2AA3, HOXA10, [NAME], ITGB3, LIPH, MAP2K1, [NAME], TNC, TUBB3, ZFYVE26 | 17
Cancer | [NAME] of tumor cell lines | 0.00707 | CNN1, FABP5 | 2
Cancer | [NAME] of cell lines | 0.0101 | CNN1, FABP5 | 2
Cancer | arrest in cell division process of colorectal cancer cell lines | 0.00558 | FGF2, ITGA5 | 2
Cancer | brain cancer | 0.00688 | FGF2, ITGB3, TNC, TUBB3 | 4
Cancer | brain tumor | 0.00688 | FGF2, ITGB3, TNC, TUBB3 | 4
Cancer | glioma | 0.00713 | FGF2, ITGB3, TNC | 3
Cancer | aggregation of pancreatic cancer cell lines | 0.00723 | FGF2 | 1
Cancer | cell death of small cell lung cancer cells | 0.00723 | FGF2 | 1
Cancer | cell movement of glioblastoma cells | 0.00723 | ITGB3 | 1
Cancer | hyperproliferation of endothelial cells | 0.00723 | FGF2 | 1
Cancer | malignancy of astrocytoma | 0.00723 | TNC | 1
Cancer | malignancy of tumor | 0.00723 | TNC | 1
Cancer | mitogenesis of bladder cancer cell lines | 0.00723 | FGF2 | 1
Cancer | mobility of brain cancer cell lines | 0.00723 | ITGA5 | 1
Cancer | mobility of tumor cell lines | 0.0108 | ITGA5 | 1
Cancer | senescence of melanoma cell lines | 0.00723 | FGF2 | 1
Cancer | head and neck cancer | 0.00819 | FGF2, [NAME], ITGB3, TNC, TUBB3 | 5
Cancer | skin tumor | 0.00971 | FGF2, ITGB3, MAP2K1, TUBB3 | 4
Cancer | growth of pancreatic cancer cell lines | 0.0101 | ITGA5, MAP2K1 | 2
Cancer | growth of hepatoma cell lines | 0.011 | FGF2, ITGA5 | 2
Cancer | breast cancer | 0.0102 | [NAME] (includes EG:59), ITGB3, MAP2K1, [NAME], TNC, TUBB3 | 6
Cancer | entry into M phase of cervical cancer cell lines | 0.0108 | MAP2K1 | 1
Cancer | apoptosis of embryonal carcinoma cell | 0.0108 | FGF2 | 1
Cancer | developmental process of cholangiocarcinoma cell lines | 0.0108 | FGF2 | 1
Cancer | developmental process of hepatoma cell lines | 0.012 | FGF2, ITGA5 | 2
Cancer | developmental process of pancreatic cancer cell lines | 0.0135 | ITGA5, MAP2K1 | 2
Cancer | radiosensitivity of cervical cancer cell lines | 0.0108 | FGF2 | 1
Cancer | skin cancer | 0.0109 | FGF2, ITGB3, MAP2K1, TUBB3 | 4
Cancer | neuroepithelial tumor | 0.0111 | FGF2, ITGB3, TNC | 3
Cancer | prostatic carcinoma | 0.0118 | CFI, ITGB3, TUBB3, ZFYVE26 | 4
Cancer | prostatic tumor | 0.012 | CFI, ITGB3, TUBB3, ZFYVE26 | 4
Cancer | anoikis of lung cancer cell lines | 0.0144 | CDCP1 | 1
Cellular Assembly and Organization | formation of filaments | 5.51e-05 | ACTA1, FGF2, [NAME], ITGB3, MAP2K1, SRF, TNC | 7
Cellular Assembly and Organization | formation of actin filaments | 7.22e-05 | FGF2, [NAME], ITGB3, MAP2K1, SRF, TNC | 6
Cellular Assembly and Organization | formation of focal adhesions | 0.0061 | FGF2, [NAME], ITGB3 | 3
Cellular Assembly and Organization | formation of Z line | 0.00723 | SRF | 1
Cellular Assembly and Organization | formation of astrocyte projections | 0.00723 | FGF2 | 1
Cellular Assembly and Organization | formation of cytoplasmic matrix | 0.00723 | FGF2 | 1
Cellular Assembly and Organization | formation of glial cell projections | 0.0108 | FGF2 | 1
Cellular Assembly and Organization | assembly of filaments | 4.8e-05 | ACTA1, FGF2, [NAME], ITGB3, TNC | 5
Cellular Assembly and Organization | assembly of actin stress fibers | 7.48e-05 | ITGA5, ITGB3, TNC | 3
Cellular Assembly and Organization | assembly of actin filaments | 7.67e-05 | FGF2, [NAME], ITGB3, TNC | 4
Cellular Assembly and Organization | assembly of thin filaments | 0.00723 | ACTA1 | 1
Cellular Assembly and Organization | maturation of synapse | 0.00362 | ITGB3 | 1
Cellular Assembly and Organization | size of vacuole | 0.00362 | ITGB3 | 1
Cellular Assembly and Organization | sprouting of sensory axons | 0.00362 | FGF2 | 1
Cellular Assembly and Organization | retraction of cytoplasmic matrix | 0.00723 | ITGB3 | 1
Cellular Assembly and Organization | localization of axons | 0.0108 | FGF2 | 1
Connective Tissue Development and Function | binding of osteoclasts | 3.84e-05 | ITGA5, ITGB3 | 2
Connective Tissue Development and Function | binding of adipose cell lines | 0.0108 | ITGA5 | 1
Connective Tissue Development and Function | adhesion of hepatic stellate cells | 7.66e-05 | ITGA5, ITGB3 | 2
Connective Tissue Development and Function | adhesion of fibroblast cell lines | 0.000343 | FGF2, [NAME], ITGB3 | 3
Connective Tissue Development and Function | adhesion of fibroblasts | 0.000371 | ITGA5, ITGB3, TNC | 3
Connective Tissue Development and Function | adhesion of bone marrow stromal cells | 0.0108 | ITGA5 | 1
Connective Tissue Development and Function | proliferation of stromal cells | 0.00309 | FGF2, HOXA10 | 2
Connective Tissue Development and Function | proliferation of fibrocytes | 0.00723 | FGF2 | 1
Connective Tissue Development and Function | entry into S phase of stromal cells | 0.00362 | FGF2 | 1
Connective Tissue Development and Function | breaking energy of fibula | 0.00362 | FGF2 | 1
Connective Tissue Development and Function | breaking strength of fibula | 0.00362 | FGF2 | 1
Connective Tissue Development and Function | contraction of granulation tissue | 0.00362 | [NAME] (includes EG:59) | 1
Connective Tissue Development and Function | fusion of coronal suture | 0.00362 | FGF2 | 1
Connective Tissue Development and Function | growth of bone marrow stromal cells | 0.00362 | FGF2 | 1
Connective Tissue Development and Function | infiltration of dermal fibroblasts | 0.00362 | ITGB3 | 1
Connective Tissue Development and Function | osteogenesis of bone marrow stromal cells | 0.00362 | FGF2 | 1
Connective Tissue Development and Function | quantity of preosteoblastic cells | 0.00362 | FGF2 | 1
Connective Tissue Development and Function | recruitment of preosteoblastic cells | 0.00362 | FGF2 | 1
Connective Tissue Development and Function | recruitment of osteoblasts | 0.0108 | FGF2 | 1
Connective Tissue Development and Function | stimulation of bone marrow stromal cells | 0.00362 | FGF2 | 1
Connective Tissue Development and Function | stimulation of stromal cells | 0.0108 | FGF2 | 1
Connective Tissue Development and Function | survival of brown adipocytes | 0.00362 | FGF2 | 1
Connective Tissue Development and Function | survival of adipocytes | 0.00723 | FGF2 | 1
Connective Tissue Development and Function | chemotaxis of fibroblasts | 0.00558 | FGF2, ITGB3 | 2
Connective Tissue Development and Function | homing of fibroblasts | 0.00593 | FGF2, ITGB3 | 2
Connective Tissue Development and Function | cell division of keratocytes | 0.00723 | FGF2 | 1
Connective Tissue Development and Function | development of stromal cells | 0.00723 | FGF2 | 1
Connective Tissue Development and Function | formation of chondrocytes | 0.00723 | ITGA5 | 1
Connective Tissue Development and Function | mass of vertebrae | 0.00723 | FGF2 | 1
Connective Tissue Development and Function | mass of bone | 0.00916 | FGF2, ITGB3 | 2
Connective Tissue Development and Function | mineralization of bone marrow stromal cells | 0.00723 | FGF2 | 1
Connective Tissue Development and Function | mitogenesis of hepatic stellate cells | 0.00723 | FGF2 | 1
Connective Tissue Development and Function | polarity of osteoclasts | 0.00723 | ITGB3 | 1
Connective Tissue Development and Function | regulation of stromal cells | 0.00723 | FGF2 | 1
Connective Tissue Development and Function | retraction of osteoclasts | 0.00723 | ITGB3 | 1
Connective Tissue Development and Function | sensitization of fibroblast cell lines | 0.00723 | FGF2 | 1
Connective Tissue Development and Function | surface area of osteoblasts | 0.00723 | FGF2 | 1
Connective Tissue Development and Function | arrest in cell cycle progression of brown adipocytes | 0.0108 | MAP2K1 | 1
Connective Tissue Development and Function | function of osteoclasts | 0.0108 | ITGB3 | 1
Connective Tissue Development and Function | mitosis of chondrocytes | 0.0108 | FGF2 | 1
Connective Tissue Development and Function | morphology of trabecular bone | 0.0108 | FGF2 | 1
Connective Tissue Development and Function | strength of vertebrae | 0.0108 | FGF2 | 1
Connective Tissue Development and Function | tubulation of Sertoli cells | 0.0108 | FGF2 | 1
Skeletal and Muscular System Development and Function | binding of osteoclasts | 3.84e-05 | ITGA5, ITGB3 | 2
Skeletal and Muscular System Development and Function | binding of bone cell lines | 0.00309 | ITGA5, ITGB3 | 2
Skeletal and Muscular System Development and Function | adhesion of vascular smooth muscle cells | 0.000454 | ITGA5, ITGB3 | 2
Skeletal and Muscular System Development and Function | adhesion of smooth muscle cells | 0.00168 | ITGA5, ITGB3 | 2
Skeletal and Muscular System Development and Function | adhesion of myofibroblasts | 0.00723 | [NAME] (includes EG:59) | 1
Skeletal and Muscular System Development and Function | proliferation of myoblasts | 0.00113 | FGF2, ITGA5 | 2
Skeletal and Muscular System Development and Function | attachment of muscle cell lines | 0.00362 | ITGB3 | 1
Skeletal and Muscular System Development and Function | bone mineral density of fracture callus | 0.00362 | FGF2 | 1
Skeletal and Muscular System Development and Function | breaking energy of fibula | 0.00362 | FGF2 | 1
Skeletal and Muscular System Development and Function | breaking strength of fibula | 0.00362 | FGF2 | 1
Skeletal and Muscular System Development and Function | contractility of myofibroblasts | 0.00362 | [NAME] (includes EG:59) | 1
Skeletal and Muscular System Development and Function | mass of diaphragm | 0.00362 | SRF | 1
Skeletal and Muscular System Development and Function | mass of extensor digitorum longus muscle | 0.00362 | SRF | 1
Skeletal and Muscular System Development and Function | mass of anterior tibial muscle | 0.00723 | SRF | 1
Skeletal and Muscular System Development and Function | mass of vertebrae | 0.00723 | FGF2 | 1
Skeletal and Muscular System Development and Function | mass of bone | 0.00916 | FGF2, ITGB3 | 2
Skeletal and Muscular System Development and Function | osteogenesis of bone marrow stromal cells | 0.00362 | FGF2 | 1
Skeletal and Muscular System Development and Function | quantity of preosteoblastic cells | 0.00362 | FGF2 | 1
Skeletal and Muscular System Development and Function | recruitment of preosteoblastic cells | 0.00362 | FGF2 | 1
Skeletal and Muscular System Development and Function | recruitment of osteoblasts | 0.0108 | FGF2 | 1
Skeletal and Muscular System Development and Function | stimulation of myoblasts | 0.00362 | FGF2 | 1
Skeletal and Muscular System Development and Function | surface area of osteoid | 0.00362 | FGF2 | 1
Skeletal and Muscular System Development and Function | surface area of osteoblasts | 0.00723 | FGF2 | 1
Skeletal and Muscular System Development and Function | volume of fracture callus | 0.00362 | FGF2 | 1
Skeletal and Muscular System Development and Function | regeneration of muscle | 0.00365 | FGF2, SRF | 2
Skeletal and Muscular System Development and Function | regeneration of anterior tibial muscle | 0.00723 | SRF | 1
Skeletal and Muscular System Development and Function | area of osteoid | 0.00723 | FGF2 | 1
Skeletal and Muscular System Development and Function | assembly of thin filaments | 0.00723 | ACTA1 | 1
Skeletal and Muscular System Development and Function | formation of fracture callus | 0.00723 | FGF2 | 1
Skeletal and Muscular System Development and Function | formation of cortical bone | 0.0108 | FGF2 | 1
Skeletal and Muscular System Development and Function | formation of joint | 0.0108 | ITGA5 | 1
Skeletal and Muscular System Development and Function | fusion of joint | 0.00723 | ITGA5 | 1
Skeletal and Muscular System Development and Function | growth of myoblasts | 0.00723 | FGF2 | 1
Skeletal and Muscular System Development and Function | growth of bone cell lines | 0.011 | FGF2, MAP2K1 | 2
Skeletal and Muscular System Development and Function | polarity of osteoclasts | 0.00723 | ITGB3 | 1
Skeletal and Muscular System Development and Function | recovery of limb | 0.00723 | FGF2 | 1
Skeletal and Muscular System Development and Function | retraction of osteoclasts | 0.00723 | ITGB3 | 1
Skeletal and Muscular System Development and Function | skeletal and muscular process of connective tissue cells | 0.00916 | FGF2, ITGB3 | 2
Skeletal and Muscular System Development and Function | function of osteoclasts | 0.0108 | ITGB3 | 1
Skeletal and Muscular System Development and Function | mitogenesis of muscle cell lines | 0.0108 | FGF2 | 1
Skeletal and Muscular System Development and Function | morphology of trabecular bone | 0.0108 | FGF2 | 1
Skeletal and Muscular System Development and Function | strength of vertebrae | 0.0108 | FGF2 | 1
Cell Death | cell death of smooth muscle cells | 4.82e-05 | ATP2B4, FGF2, ITGB3, MAP2K1 | 4
Cell Death | cell death of stem cells | 0.00053 | FGF2, [NAME], SRF | 3
Cell Death | cell death of intestinal cell lines | 0.00336 | ITGA5, MAP2K1 | 2
Cell Death | cell death of muscle cells | 0.00369 | ATP2B4, FGF2, ITGB3, MAP2K1 | 4
Cell Death | cell death of embryonic stem cells | 0.0063 | ITGA5, SRF | 2
Cell Death | cell death of small cell lung cancer cells | 0.00723 | FGF2 | 1
Cell Death | cell death of multilineage progenitor cells | 0.0144 | FGF2 | 1
Cell Death | survival of skin cell lines | 7.66e-05 | FGF2, ITGB3 | 2
Cell Death | survival of lung cancer cell lines | 0.00258 | FGF2, TUBB3 | 2
Cell Death | survival of cell lines | 0.00316 | FGF2, [NAME], ITGB3, MAP2K1, PPP1R9A, RFK, TUBB3 | 7
Cell Death | survival of brown adipocytes | 0.00362 | FGF2 | 1
Cell Death | survival of crypt cells | 0.00362 | FGF2 | 1
Cell Death | survival of gastrointestinal cells | 0.00362 | FGF2 | 1
Cell Death | survival of striatal neurons | 0.00362 | FGF2 | 1
Cell Death | survival of endothelial cells | 0.00523 | FGF2, ITGB3 | 2
Cell Death | survival of RPE cells | 0.00723 | FGF2 | 1
Cell Death | survival of adipocytes | 0.00723 | FGF2 | 1
Cell Death | survival of lymphatic endothelial cells | 0.00723 | FGF2 | 1
Cell Death | survival of mesenchymal cells | 0.0108 | FGF2 | 1
Cell Death | apoptosis of stem cells | 0.000268 | FGF2, [NAME], SRF | 3
Cell Death | apoptosis of smooth muscle cells | 0.000867 | ATP2B4, ITGB3, MAP2K1 | 3
Cell Death | apoptosis of intestinal cell lines | 0.00336 | ITGA5, MAP2K1 | 2
Cell Death | apoptosis of oligodendrocyte precursor cells | 0.00362 | FGF2 | 1
Cell Death | apoptosis of embryonic stem cells | 0.00365 | ITGA5, SRF | 2
Cell Death | apoptosis of embryonal carcinoma cell | 0.0108 | FGF2 | 1
Cell Death | apoptosis of multilineage progenitor cells | 0.0108 | FGF2 | 1
Cell Death | anoikis | 0.00222 | CDCP1, [NAME], MAP2K1 | 3
Cell Death | anoikis of lung cancer cell lines | 0.0144 | CDCP1 | 1
Cell Death | colony survival of carcinoma cell lines | 0.00362 | TUBB3 | 1
Cell Death | colony survival of lung cancer cell lines | 0.00362 | TUBB3 | 1
Cell Death | repopulation of oligodendrocytes | 0.00362 | FGF2 | 1
Cell Death | self-renewal of progenitor cells | 0.00362 | FGF2 | 1
Cell Death | regeneration of pyramidal neurons | 0.00723 | FGF2 | 1